Logo image of CPRT

COPART INC (CPRT) Stock Fundamental Analysis

NASDAQ:CPRT - Nasdaq - US2172041061 - Common Stock - Currency: USD

49.32  +0.24 (+0.49%)

After market: 49.34 +0.02 (+0.04%)

Fundamental Rating

7

Overall CPRT gets a fundamental rating of 7 out of 10. We evaluated CPRT against 83 industry peers in the Commercial Services & Supplies industry. CPRT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, CPRT is valued expensive at the moment. These ratings would make CPRT suitable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CPRT was profitable.
In the past year CPRT had a positive cash flow from operations.
In the past 5 years CPRT has always been profitable.
Each year in the past 5 years CPRT had a positive operating cash flow.
CPRT Yearly Net Income VS EBIT VS OCF VS FCFCPRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

CPRT has a Return On Assets of 15.29%. This is amongst the best in the industry. CPRT outperforms 92.77% of its industry peers.
CPRT has a Return On Equity of 16.84%. This is in the better half of the industry: CPRT outperforms 78.31% of its industry peers.
CPRT's Return On Invested Capital of 14.50% is amongst the best of the industry. CPRT outperforms 86.75% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CPRT is significantly above the industry average of 11.67%.
The last Return On Invested Capital (14.50%) for CPRT is well below the 3 year average (19.14%), which needs to be investigated, but indicates that CPRT had better years and this may not be a problem.
Industry RankSector Rank
ROA 15.29%
ROE 16.84%
ROIC 14.5%
ROA(3y)18.36%
ROA(5y)19.17%
ROE(3y)20.79%
ROE(5y)23.4%
ROIC(3y)19.15%
ROIC(5y)20.04%
CPRT Yearly ROA, ROE, ROICCPRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 32.21%, CPRT belongs to the top of the industry, outperforming 96.39% of the companies in the same industry.
In the last couple of years the Profit Margin of CPRT has grown nicely.
CPRT has a Operating Margin of 35.80%. This is amongst the best in the industry. CPRT outperforms 98.80% of its industry peers.
CPRT's Operating Margin has been stable in the last couple of years.
With a decent Gross Margin value of 44.51%, CPRT is doing good in the industry, outperforming 75.90% of the companies in the same industry.
CPRT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 35.8%
PM (TTM) 32.21%
GM 44.51%
OM growth 3Y-4.2%
OM growth 5Y1.12%
PM growth 3Y-2.57%
PM growth 5Y2.11%
GM growth 3Y-3.25%
GM growth 5Y0.69%
CPRT Yearly Profit, Operating, Gross MarginsCPRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

CPRT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CPRT has more shares outstanding
CPRT has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CPRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CPRT Yearly Shares OutstandingCPRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CPRT Yearly Total Debt VS Total AssetsCPRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CPRT has an Altman-Z score of 34.66. This indicates that CPRT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CPRT (34.66) is better than 98.80% of its industry peers.
There is no outstanding debt for CPRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 34.66
ROIC/WACC1.43
WACC10.11%
CPRT Yearly LT Debt VS Equity VS FCFCPRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

CPRT has a Current Ratio of 8.16. This indicates that CPRT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.16, CPRT belongs to the best of the industry, outperforming 97.59% of the companies in the same industry.
CPRT has a Quick Ratio of 8.09. This indicates that CPRT is financially healthy and has no problem in meeting its short term obligations.
CPRT's Quick ratio of 8.09 is amongst the best of the industry. CPRT outperforms 97.59% of its industry peers.
Industry RankSector Rank
Current Ratio 8.16
Quick Ratio 8.09
CPRT Yearly Current Assets VS Current LiabilitesCPRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.57% over the past year.
CPRT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.32% yearly.
Looking at the last year, CPRT shows a quite strong growth in Revenue. The Revenue has grown by 10.21% in the last year.
The Revenue has been growing by 15.72% on average over the past years. This is quite good.
EPS 1Y (TTM)8.57%
EPS 3Y-9.17%
EPS 5Y4.32%
EPS Q2Q%7.69%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y16.31%
Revenue growth 5Y15.72%
Sales Q2Q%7.49%

3.2 Future

CPRT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.98% yearly.
Based on estimates for the next years, CPRT will show a quite strong growth in Revenue. The Revenue will grow by 11.53% on average per year.
EPS Next Y14.25%
EPS Next 2Y12.78%
EPS Next 3Y13.05%
EPS Next 5Y11.98%
Revenue Next Year9.97%
Revenue Next 2Y9.3%
Revenue Next 3Y9.79%
Revenue Next 5Y11.53%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CPRT Yearly Revenue VS EstimatesCPRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
CPRT Yearly EPS VS EstimatesCPRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 32.45 indicates a quite expensive valuation of CPRT.
The rest of the industry has a similar Price/Earnings ratio as CPRT.
When comparing the Price/Earnings ratio of CPRT to the average of the S&P500 Index (27.45), we can say CPRT is valued inline with the index average.
With a Price/Forward Earnings ratio of 27.90, CPRT can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as CPRT.
When comparing the Price/Forward Earnings ratio of CPRT to the average of the S&P500 Index (21.90), we can say CPRT is valued slightly more expensively.
Industry RankSector Rank
PE 32.45
Fwd PE 27.9
CPRT Price Earnings VS Forward Price EarningsCPRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPRT is on the same level as its industry peers.
CPRT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 40.34
EV/EBITDA 22.07
CPRT Per share dataCPRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPRT does not grow enough to justify the current Price/Earnings ratio.
CPRT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CPRT's earnings are expected to grow with 13.05% in the coming years.
PEG (NY)2.28
PEG (5Y)7.51
EPS Next 2Y12.78%
EPS Next 3Y13.05%

0

5. Dividend

5.1 Amount

No dividends for CPRT!.
Industry RankSector Rank
Dividend Yield N/A

COPART INC

NASDAQ:CPRT (7/3/2025, 5:00:01 PM)

After market: 49.34 +0.02 (+0.04%)

49.32

+0.24 (+0.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-22 2025-05-22/amc
Earnings (Next)09-02 2025-09-02/amc
Inst Owners86.84%
Inst Owner Change2.39%
Ins Owners8.65%
Ins Owner Change-0.53%
Market Cap47.65B
Analysts78.82
Price Target63.5 (28.75%)
Short Float %2.22%
Short Ratio2.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.26%
Min EPS beat(2)-1.18%
Max EPS beat(2)5.7%
EPS beat(4)1
Avg EPS beat(4)-1.84%
Min EPS beat(4)-10.92%
Max EPS beat(4)5.7%
EPS beat(8)3
Avg EPS beat(8)-1.19%
EPS beat(12)6
Avg EPS beat(12)-0.45%
EPS beat(16)10
Avg EPS beat(16)0.61%
Revenue beat(2)1
Avg Revenue beat(2)-1.24%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)0.81%
Revenue beat(4)2
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-3.29%
Max Revenue beat(4)2.21%
Revenue beat(8)5
Avg Revenue beat(8)-0.44%
Revenue beat(12)6
Avg Revenue beat(12)-0.56%
Revenue beat(16)10
Avg Revenue beat(16)1.04%
PT rev (1m)-0.54%
PT rev (3m)-0.4%
EPS NQ rev (1m)-4.98%
EPS NQ rev (3m)-4.98%
EPS NY rev (1m)-1.22%
EPS NY rev (3m)-0.34%
Revenue NQ rev (1m)-2.84%
Revenue NQ rev (3m)-2.84%
Revenue NY rev (1m)-0.71%
Revenue NY rev (3m)-0.58%
Valuation
Industry RankSector Rank
PE 32.45
Fwd PE 27.9
P/S 10.38
P/FCF 40.34
P/OCF 26.46
P/B 5.43
P/tB 5.81
EV/EBITDA 22.07
EPS(TTM)1.52
EY3.08%
EPS(NY)1.77
Fwd EY3.58%
FCF(TTM)1.22
FCFY2.48%
OCF(TTM)1.86
OCFY3.78%
SpS4.75
BVpS9.09
TBVpS8.48
PEG (NY)2.28
PEG (5Y)7.51
Profitability
Industry RankSector Rank
ROA 15.29%
ROE 16.84%
ROCE 18.23%
ROIC 14.5%
ROICexc 28.23%
ROICexgc 32.32%
OM 35.8%
PM (TTM) 32.21%
GM 44.51%
FCFM 25.73%
ROA(3y)18.36%
ROA(5y)19.17%
ROE(3y)20.79%
ROE(5y)23.4%
ROIC(3y)19.15%
ROIC(5y)20.04%
ROICexc(3y)30.14%
ROICexc(5y)28.88%
ROICexgc(3y)50.08%
ROICexgc(5y)42.59%
ROCE(3y)24.07%
ROCE(5y)25.2%
ROICexcg growth 3Y-0.59%
ROICexcg growth 5Y-0.42%
ROICexc growth 3Y-0.76%
ROICexc growth 5Y0.83%
OM growth 3Y-4.2%
OM growth 5Y1.12%
PM growth 3Y-2.57%
PM growth 5Y2.11%
GM growth 3Y-3.25%
GM growth 5Y0.69%
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 288.39%
Cap/Sales 13.49%
Interest Coverage 521.3
Cash Conversion 96.88%
Profit Quality 79.89%
Current Ratio 8.16
Quick Ratio 8.09
Altman-Z 34.66
F-Score5
WACC10.11%
ROIC/WACC1.43
Cap/Depr(3y)278.53%
Cap/Depr(5y)355.91%
Cap/Sales(3y)11.68%
Cap/Sales(5y)15.82%
Profit Quality(3y)72%
Profit Quality(5y)63.79%
High Growth Momentum
Growth
EPS 1Y (TTM)8.57%
EPS 3Y-9.17%
EPS 5Y4.32%
EPS Q2Q%7.69%
EPS Next Y14.25%
EPS Next 2Y12.78%
EPS Next 3Y13.05%
EPS Next 5Y11.98%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y16.31%
Revenue growth 5Y15.72%
Sales Q2Q%7.49%
Revenue Next Year9.97%
Revenue Next 2Y9.3%
Revenue Next 3Y9.79%
Revenue Next 5Y11.53%
EBIT growth 1Y2.53%
EBIT growth 3Y11.42%
EBIT growth 5Y17.02%
EBIT Next Year19.39%
EBIT Next 3Y16.01%
EBIT Next 5Y13.89%
FCF growth 1Y35.89%
FCF growth 3Y22.13%
FCF growth 5Y28.66%
OCF growth 1Y36.56%
OCF growth 3Y14.12%
OCF growth 5Y17.89%